Crinetics Pharmaceuticals, Inc. (CRNX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.32B | 1.05B | 1.12B | 1.22B | 1.29B | 1.38B | 877.59M | 874.78M | 917.23M | 574.15M | 575.76M | 284.81M |
| Cash & Short-Term Investments | 1.29B | 1.03B | 1.09B | 1.2B | 1.27B | 1.35B | 862.67M | 862.95M | 900.96M | 558.55M | 554.65M | 264.53M |
| Cash Only | 114.34M | 101.54M | 110.9M | 53.73M | 94.57M | 264.55M | 317.27M | 302.16M | 395.92M | 54.9M | 142.79M | 39.55M |
| Short-Term Investments | 1.18B | 926.35M | 981.39M | 1.14B | 1.18B | 1.09B | 545.4M | 560.79M | 505.04M | 503.66M | 411.86M | 224.98M |
| Accounts Receivable | 5.68M | 592K | 0 | 0 | 7.31M | 8.47M | 7.03M | 5.1M | 9.44M | 9.35M | 11.64M | 2.38M |
| Days Sales Outstanding | 26.31 | 8.84 | - | - | 1.97K | - | - | 1.66K | 1.34K | - | 1.86K | 217.88 |
| Inventory | 3.06M | 2.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 1.14K | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 22.36M | 17.84M | 500K | 20.9M | 3.2M | 1.71M | 1.49M | 1.51M | 3.56M | 1.58M | 3.52M | 2.76M |
| Total Non-Current Assets | 78.91M | 87.15M | 74.76M | 72.31M | 70.27M | 59.2M | 59.79M | 60.76M | 60.92M | 61.2M | 65.78M | 8.44M |
| Property, Plant & Equipment | 53.29M | 54.79M | 55.52M | 56.57M | 55.32M | 55.58M | 55.98M | 57.26M | 57.63M | 57.43M | 57.81M | 4.47M |
| Fixed Asset Turnover | 0.20x | 0.11x | 0.00x | 0.02x | 0.01x | - | - | 0.01x | 0.01x | - | 0.01x | 0.22x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 800K | 800K | 0 | 800K | 0 | 2M | 1.3M | 2M | 1.3M | 1.77M | 5.97M | 0 |
| Other Non-Current Assets | 24.82M | 22.33M | 19.23M | 14.94M | 14.95M | 1.63M | 2.51M | 1.5M | 2M | 2M | 2M | 3.97M |
| Total Assets | 1.4B | 1.14B | 1.2B | 1.29B | 1.36B | 1.43B | 937.37M | 935.53M | 978.15M | 635.35M | 641.54M | 293.25M |
| Asset Turnover | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | - | - | 0.00x | 0.00x | - | 0.00x | 0.00x |
| Asset Growth % | 2.94% | -20.85% | 27.59% | 37.84% | 39.17% | 125.79% | 46.11% | 219.02% | 211.5% | 80.41% | 66.68% | -30.46% |
| Total Current Liabilities | 71.09M | 85.07M | 74.16M | 68.4M | 57.31M | 59.68M | 53.56M | 54.38M | 51.77M | 43.94M | 40.46M | 32.61M |
| Accounts Payable | 12.88M | 22.61M | 6.11M | 11.32M | 9.84M | 5.85M | 4.94M | 8.87M | 10.76M | 6.55M | 5.84M | 4.84M |
| Days Payables Outstanding | 7.99K | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 6.54M | 6.49M | 0 | 0 | 0 | 0 | 0 | 0 | 5.79M | 4.17M | 3.99M | 0 |
| Deferred Revenue (Current) | 1.27M | 1.24M | 0 | 1.9M | 2.21M | 2.18M | 1.69M | 2.56M | 2.46M | 2.06M | 1.66M | 2.08M |
| Other Current Liabilities | 24.61M | 19.16M | 1.64M | 48.56M | 16.61M | 10K | 26.19M | 20.38M | 17.93M | 16.65M | 16.09M | 8.6M |
| Current Ratio | 18.60x | 12.32x | 15.12x | 17.80x | 22.53x | 23.04x | 16.38x | 16.09x | 17.72x | 13.07x | 14.23x | 8.73x |
| Quick Ratio | 18.56x | 12.30x | 15.12x | 17.80x | 22.53x | 23.04x | 16.38x | 16.09x | 17.72x | 13.07x | 14.23x | 8.73x |
| Cash Conversion Cycle | -6.81K | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 49.59M | 58.34M | 49.71M | 49.65M | 50.02M | 50.1M | 50.83M | 50.4M | 51.45M | 52.3M | 53.33M | 6.53M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 41.32M | 42.05M | 42.7M | 43.33M | 43.94M | 44.57M | 45.13M | 45.87M | 46.71M | 47.55M | 48.18M | 1.46M |
| Deferred Tax Liabilities | 0 | 9.24M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 4.93M | 3.24M | 7M | 2.33M | 1.77M | 829K | 511K | 202K | 0 | 0 | 0 | 0 |
| Total Liabilities | 120.68M | 143.41M | 123.86M | 118.05M | 107.33M | 109.79M | 104.39M | 104.77M | 103.22M | 96.25M | 93.79M | 39.14M |
| Total Debt | 47.85M | 48.54M | 49.14M | 49.94M | 50.82M | 51.72M | 52.54M | 53.32M | 52.5M | 51.73M | 52.17M | 2.56M |
| Net Debt | -66.49M | -52.99M | -61.76M | -3.79M | -43.75M | -212.82M | -264.73M | -248.84M | -343.42M | -3.17M | -90.62M | -36.99M |
| Debt / Equity | 0.04x | 0.05x | 0.05x | 0.04x | 0.04x | 0.04x | 0.06x | 0.06x | 0.06x | 0.10x | 0.10x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.28B | 992.08M | 1.07B | 1.17B | 1.25B | 1.32B | 832.98M | 830.76M | 874.93M | 539.11M | 547.75M | 254.12M |
| Equity Growth % | 2.12% | -25.11% | 28.71% | 41.02% | 43.33% | 145.74% | 52.07% | 226.92% | 212.11% | 70.43% | 55.89% | -34.2% |
| Book Value per Share | 12.30 | 10.55 | 11.38 | 12.49 | 13.47 | 14.48 | 10.40 | 10.51 | 12.10 | 8.03 | 9.64 | 4.68 |
| Total Shareholders' Equity | 1.28B | 992.08M | 1.07B | 1.17B | 1.25B | 1.32B | 832.98M | 830.76M | 874.93M | 539.11M | 547.75M | 254.12M |
| Common Stock | 2.83B | 2.41B | 2.36B | 2.33B | 2.3B | 2.28B | 1.7B | 1.63B | 1.6B | 1.19B | 1.14B | 791.97M |
| Retained Earnings | -1.55B | -1.42B | -1.29B | -1.16B | -1.05B | -952.11M | -871.51M | -794.69M | -720.63M | -653.7M | -593.61M | -536.15M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -2.29M | 1.75M | 2.08M | 1.62M | 2M | 963K | 2.04M | -190K | 150K | 977K | -865K | -1.71M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |